PROM1 and hepatocellular carcinoma: Schrader et al. discovered that, in HCC cells treated with chemotherapeutic agent cisplatin and 5-Fluorouracil (5-FU), an enrichment of cells with surface marker CD133, CXCR4 and CD44 is observed in the soft supports instead of the hard ones.